Clonidine for the treatment of psychiatric conditions and symptoms a review of clinical effectiveness, safety, and guidelines
Previous Canadian Agency for Drugs and Technologies in Health (CADTH) reports pertaining to the management of attention deficit hyperactive disorder (ADHD) and post-traumatic stress disorder (PTSD) have identified evidence-based guidelines that suggest clonidine can be used for the treatment of PTSD...
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
February 21, 2018, 2018
|
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references